Titan Bio-Tech [TITANBIO] vs Biocon [BIOCON] Detailed Stock Comparison

Titan Bio-Tech

BSE
Loading...

Biocon

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Titan Bio-Tech wins in 12 metrics, Biocon wins in 8 metrics, with 0 ties. Titan Bio-Tech appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTitan Bio-TechBioconBetter
P/E Ratio (TTM)35.79108.04Titan Bio-Tech
Price-to-Book Ratio5.131.92Biocon
Debt-to-Equity Ratio1.8266.26Titan Bio-Tech
PEG Ratio4.99-1.13Biocon
EV/EBITDA30.0319.02Biocon
Profit Margin (TTM)13.76%2.44%Titan Bio-Tech
Operating Margin (TTM)16.31%7.46%Titan Bio-Tech
EBITDA Margin (TTM)16.31%7.46%Titan Bio-Tech
Return on Equity14.04%3.66%Titan Bio-Tech
Return on Assets (TTM)12.32%1.72%Titan Bio-Tech
Free Cash Flow (TTM)$106.79M$17.18BBiocon
Dividend Yield0.42%0.26%Titan Bio-Tech
1-Year Return33.04%1.70%Titan Bio-Tech
Price-to-Sales Ratio (TTM)4.932.93Biocon
Enterprise Value$7.85B$613.72BBiocon
EV/Revenue Ratio4.913.89Biocon
Gross Profit Margin (TTM)48.49%64.06%Biocon
Revenue per Share (TTM)$193$131Titan Bio-Tech
Earnings per Share (Diluted)$26.62$3.21Titan Bio-Tech
Beta (Stock Volatility)0.230.23Titan Bio-Tech
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Titan Bio-Tech vs Biocon Stock Performance Analysis

Loading Price Chart...

Titan Bio-Tech
Biocon
Titan Bio-Tech Stock Overview | Biocon Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Titan Bio-Tech1.69%7.36%37.60%123.15%104.11%26.96%
Biocon1.67%3.94%-2.57%-5.93%1.88%-4.49%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Titan Bio-Tech33.04%252.87%522.82%3,129.33%2,862.69%5,150.95%
Biocon1.70%24.54%-22.05%376.72%414.31%787.95%

News Based Sentiment: Titan Bio-Tech vs Biocon

Titan Bio-Tech

News based Sentiment: MIXED

September presented a mixed bag for Titan Biotech. While the company showcased impressive revenue growth and financial stability, the insider selling by a promoter raises concerns about confidence in the short-term outlook. This combination of positive and negative signals makes it a significant month for investors to assess the company's trajectory.

View Titan Bio-Tech News Sentiment Analysis

Biocon

News based Sentiment: POSITIVE

The month's narrative centers around Biocon's positive developments – entry into the US market with biosimilars and consideration of early NCD redemption – which suggest a strengthening investment case. While trading volume was lower than average, the overall tone is optimistic.

View Biocon News Sentiment Analysis

Performance & Financial Health Analysis: Titan Bio-Tech vs Biocon

MetricTITANBIOBIOCON
Market Information
Market Cap i₹8.10B₹470.24B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i31,2823,963,018
90 Day Avg. Volume i32,4752,555,718
Last Close₹968.80₹352.25
52 Week Range₹373.65 - ₹1,017.00₹291.00 - ₹406.00
% from 52W High-4.74%-13.24%
All-Time High₹1,017.85 (Oct 21, 2024)₹487.75 (Dec 21, 2020)
% from All-Time High-4.82%-27.78%
Growth Metrics
Quarterly Revenue Growth0.08%0.15%
Quarterly Earnings Growth0.07%-0.95%
Financial Health
Profit Margin (TTM) i0.14%0.02%
Operating Margin (TTM) i0.16%0.07%
Return on Equity (TTM) i0.14%0.04%
Debt to Equity (MRQ) i1.8266.26
Cash & Liquidity
Book Value per Share (MRQ)₹185.75₹180.66
Cash per Share (MRQ)₹6.72₹38.10
Operating Cash Flow (TTM) i₹197.75M₹17.78B
Levered Free Cash Flow (TTM) i₹215.32M₹10.13B
Dividends
Last 12-Month Dividend Yield i0.42%0.26%
Last 12-Month Dividend i₹4.00₹1.00

Valuation & Enterprise Metrics Analysis: Titan Bio-Tech vs Biocon

MetricTITANBIOBIOCON
Price Ratios
P/E Ratio (TTM) i35.79108.04
Forward P/E iN/A34.96
PEG Ratio i4.99-1.13
Price to Sales (TTM) i4.932.93
Price to Book (MRQ) i5.131.92
Market Capitalization
Market Capitalization i₹8.10B₹470.24B
Enterprise Value i₹7.85B₹613.72B
Enterprise Value Metrics
Enterprise to Revenue i4.913.89
Enterprise to EBITDA i30.0319.02
Risk & Other Metrics
Beta i0.230.23
Book Value per Share (MRQ) i₹185.75₹180.66

Financial Statements Comparison: Titan Bio-Tech vs Biocon

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TITANBIOBIOCON
Revenue/Sales i₹464.96M₹39.10B
Cost of Goods Sold i₹239.50M₹14.05B
Gross Profit i₹225.47M₹25.05B
Research & Development iN/A₹-346.00M
Operating Income (EBIT) i₹75.85M₹2.94B
EBITDA i₹94.59M₹8.29B
Pre-Tax Income i₹81.12M₹969.00M
Income Tax i₹19.51M₹77.00M
Net Income (Profit) i₹68.63M₹892.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TITANBIOBIOCON
Cash & Equivalents i₹51.28M₹32.27B
Total Current Assets i₹790.38M₹162.86B
Total Current Liabilities i₹177.36M₹143.34B
Long-Term Debt i₹4.19M₹129.45B
Total Shareholders Equity i₹1.53B₹277.13B
Retained Earnings i₹1.36B₹189.59B
Property, Plant & Equipment i₹571.62M₹4.32B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TITANBIOBIOCON
Operating Cash Flow i₹45.62MN/A
Capital Expenditures i₹-33.58MN/A
Free Cash Flow i₹12.24MN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTITANBIOBIOCON
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i31,2823,963,018
Average Daily Volume (90 Day) i32,4752,555,718
Shares Outstanding i8.26M1.20B
Float Shares i2.65M524.74M
% Held by Insiders i0.67%0.55%
% Held by Institutions i0.00%0.24%

Dividend Analysis & Yield Comparison: Titan Bio-Tech vs Biocon

MetricTITANBIOBIOCON
Last 12-Month Dividend i₹4.00₹1.00
Last 12-Month Dividend Yield i0.42%0.26%
3-Year Avg Annual Dividend i₹1.93₹1.33
3-Year Avg Dividend Yield i0.34%0.36%
3-Year Total Dividends i₹5.80₹4.00
Ex-Dividend DateSep 19, 2025Jul 04, 2025